204 related articles for article (PubMed ID: 32640498)
41. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
[TBL] [Abstract][Full Text] [Related]
42. Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center experience.
Sestili S; Eder S; Belhocine R; Dulery R; Battipaglia G; Brissot E; Mediavilla C; Banet A; van de Wyngaert Z; Paviglianiti A; Ledraa T; Bonin A; Mohty M; Malard F
Cytotherapy; 2020 Aug; 22(8):445-449. PubMed ID: 32434750
[TBL] [Abstract][Full Text] [Related]
43. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
[TBL] [Abstract][Full Text] [Related]
44. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD.
Jagasia M; Scheid C; Socié G; Ayuk FA; Tischer J; Donato ML; Bátai Á; Chen H; Chen SC; Chin T; Boodée H; Mitri G; Greinix HT
Blood Adv; 2019 Jul; 3(14):2218-2229. PubMed ID: 31332045
[TBL] [Abstract][Full Text] [Related]
45. Extracorporeal Photopheresis for Second-Line Treatment of Chronic Graft-versus-Host Diseases: Results from a Health Technology Assessment in Italy.
de Waure C; Capri S; Veneziano MA; Specchia ML; Cadeddu C; Di Nardo F; Ferriero AM; Gennari F; Hamilton C; Mancuso A; Quaranta G; Raponi M; Valerio L; Gensini G; Ricciardi W
Value Health; 2015 Jun; 18(4):457-66. PubMed ID: 26091600
[TBL] [Abstract][Full Text] [Related]
46. [Extracorporeal photopheresis in treatment of chronic graft versus host disease].
Bojanić I; Seiwerth RS; Mazić S; Dubravcić K; Batinić D; Cepulić BG; Labar B
Lijec Vjesn; 2013; 135(5-6):139-44. PubMed ID: 23898694
[TBL] [Abstract][Full Text] [Related]
47. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
[TBL] [Abstract][Full Text] [Related]
48. A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells.
Gandelman JS; Song DJ; Chen H; Engelhardt BG; Chen YB; Clark WB; Giver CR; Waller EK; Jung DK; Jagasia M
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2373-2380. PubMed ID: 29981848
[TBL] [Abstract][Full Text] [Related]
49. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience.
Batgi H; Dal MS; Erkurt MA; Kuku I; Kurtoglu E; Hindilerden IY; Kaya E; Berber I; Ulas T; Altuntas F
Transfus Apher Sci; 2021 Oct; 60(5):103242. PubMed ID: 34420882
[TBL] [Abstract][Full Text] [Related]
50. Mini photopheresis for refractory chronic graft-versus-host disease in children and adolescents.
Verdú-Amorós J; Woessmann W; Maecker-Kolhoff B; Schulz A; Strauss G; Bein G; Hackstein H
Transfusion; 2018 Nov; 58(11):2495-2500. PubMed ID: 30291766
[TBL] [Abstract][Full Text] [Related]
51. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
[TBL] [Abstract][Full Text] [Related]
52. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.
Greinix HT; van Besien K; Elmaagacli AH; Hillen U; Grigg A; Knobler R; Parenti D; Reddy V; Theunissen K; Michallet M; Flowers ME;
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1775-82. PubMed ID: 21621629
[TBL] [Abstract][Full Text] [Related]
53. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of lymphocytes inactivation by extracorporeal photopheresis using tetrazolium salt based-assay.
Chieregato K; Alghisi A; Borghero C; Elice F; Raimondi R; Zanetti E; Rodeghiero F; Astori G
Transfus Apher Sci; 2015 Oct; 53(2):242-5. PubMed ID: 26051797
[TBL] [Abstract][Full Text] [Related]
55. Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD).
Solh MM; Farnham C; Solomon SR; Bashey A; Morris LE; Holland HK; Zhang X
Bone Marrow Transplant; 2023 Feb; 58(2):168-174. PubMed ID: 36352015
[TBL] [Abstract][Full Text] [Related]
56. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
57. Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.
Taverna F; Coluccia P; Arienti F; Birolini A; Terranova L; Mazzocchi A; Rini F; Mariani L; Melani C; Ravagnani F
J Clin Apher; 2015 Jun; 30(3):162-70. PubMed ID: 25220858
[TBL] [Abstract][Full Text] [Related]
58. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience.
Calore E; Marson P; Pillon M; Tumino M; Tison T; Mainardi C; De Silvestro G; Rossin S; Franceschetto G; Carraro E; Pescarin M; Varotto S; Destro R; Gazzola MV; Basso G; Messina C
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1963-72. PubMed ID: 26183078
[TBL] [Abstract][Full Text] [Related]
59. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
Akhtari M; Giver CR; Ali Z; Flowers CR; Gleason CL; Hillyer CD; Kaufman J; Khoury HJ; Langston AA; Lechowicz MJ; Lonial S; Renfroe HM; Roback JD; Tighiouart M; Vaughn L; Waller EK
Transfusion; 2010 Nov; 50(11):2424-31. PubMed ID: 20529004
[TBL] [Abstract][Full Text] [Related]
60. Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure.
Linn SM; Novitzky-Basso I; Patriquin C; Pasic I; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Barth D; Kim DDH
Leuk Res; 2023 Nov; 134():107387. PubMed ID: 37734221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
